Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug.
See the original post here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc.
See the rest here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
Latisse lash lengthener has its fans and detractors
Many users swear by its effectiveness, but the drug, developed to treat glaucoma, can have unpleasant side effects. Taking a prescription drug for a cosmetic side effect — at the risk of other side effects — may seem risky
See the original post:
Latisse lash lengthener has its fans and detractors
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts